Drugdiscovery >> Pharmaceutical Companies >> News
4851
Views
AstraZeneca: New Partnership in Combat Kidney Disease - drugdiscovery.com
AstraZeneca: New Partnership in Combat Kidney Disease - drugdiscovery.com


Evotec AG and AstraZeneca step into fellowship to fight kidney disease. The two giants are working on finding new possibilities and components, which might modify disease and help the quick recovery of patients.
Read More >>


Tags: contrect, Evotec AG, AstraZeneca, kidney - October 26, 2013
Related Articles
1631
Views
Life Tech -  RainTree partnership Life Tech - RainTree partnership
Life Technologies Corporation and RainTree Oncology Services have entered into a collaboration agreement designed to further the advancement of personalized care for cancer patients. Read More >>

Tags: Life Technologies Corporation, RainTree Oncology Services, cooperation, partnership, personalized care, cancer patients

4631
Views
Celgene, PharmAkea partnership Celgene, PharmAkea partnership
Celgene has entered into a collaboration with a biotech upstart PharmAkea Therapeutics, signing a three-deal to collaborate on cancer and cystic fibrosis drug development. Read More >>

Tags: Celgene, PharmAkea Therapeutics, partnership, collaboration, cancer, cystic fibrosis, CF, drug development

3999
Views
The price of AstraZeneca 's stock increased after Pfizer's offer The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. Read More >>

Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca,Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold

4781
Views
What is happening with AstraZeneca. What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies? Read More >>

Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business.

2875
Views
AstraZeneca buys anti-diabetes giant AstraZeneca buys anti-diabetes giant
AstraZeneca PLC will buy out Bristol-Myers Squibb. This opens a new market for the anglo-swedish company to sell drugs. According to the company this helps to make diabetes drugs free and good Read More >>

Tags: AstraZeneca,Birstol Myers Squibb, diabeters

4043
Views
AstraZeneca links with privately held company to research cancer AstraZeneca links with privately held company to research cancer
AstraZeneca has announced that its biologic development arm is going to co-operate with Immunocore Limited. This is a privately held company and works on T-cell related researches. Read More >>

Tags: T-cell, AstraZeneca, Immunocore, co-operation

3155
Views
Shire and Santaris  extend their partnership Shire and Santaris extend their partnership
The two companies decided to extend the agreement for discovering drug targets for rare genetic diseases that was signed in 2009, this way allowing Shire to nominate extra collaboration targets for Read More >>

Tags: Shire, Santaris, partnership, colaboration

1483
Views
AstraZeneca CFO to join BG AstraZeneca CFO to join BG
Simon Lowth, chief financial officer at AstraZeneca, is leaving the pharmaceutical company to take on the same role at oil and gas group BG. Read More >>

Tags: AstraZeneca,Simon Lowth

3954
Views
AstraZeneca and Pfizer merger: Do cancer patients loose? AstraZeneca and Pfizer merger: Do cancer patients loose?
Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others. Read More >>

Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition

4570
Views
AstraZeneca pleased with quarter despite profits fall AstraZeneca pleased with quarter despite profits fall
Patent expiries continue to hurt sales and earnings Read More >>

Tags: AstraZeneca, profits

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013